ライフサイエンスコーパス: transfusion medicine

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 t or ameliorate this serious complication in transfusion medicine.

2 genotyping to prenatal practice and clinical transfusion medicine.

3 applied to mitigate the transmission risk in transfusion medicine.

4 ythrocyte proteins important in neonatal and transfusion medicine.

5 for the fields of erythroid cell biology and transfusion medicine.

6 ) offers exciting clinical opportunities for transfusion medicine.

7 cted antigens and describes implications for transfusion medicine.

8 applied to mitigate the transmission risk in transfusion medicine.

9 is considered a major public health issue in transfusion medicine.

10 Thus, ALA may be a promising tool in transfusion medicine and in high turnover/high activatio

11 clinical decision support systems (CDSS) in transfusion medicine and other novel ways information te

12 relevant to bleeding and clotting disorders, transfusion medicine and regulation of angiogenesis.

13 Transfusion medicine and treatments of hematopoietic dis

14 al transfusion safety are a top priority for transfusion medicine, and will depend on a combined appr

15 f we decide that cost-utility thresholds for transfusion medicine are appropriately several fold high

16 EPC-TP likely represents a paradigm shift in transfusion medicine because of its potential to continu

17 bility could be explored for applications in transfusion medicine but also for delivery of nucleic ac

18 Thrombopoietin may be useful in transfusion medicine by: 1) reducing the demand for plat

19 Over the past 60 years, the transfusion medicine community has attained significant

20 ethods were introduced to the blood bank and transfusion medicine community more than a decade ago af

21 database should be of use to members of the transfusion medicine community, those interested in stud

22 tact RBC may have significant application in transfusion medicine, especially for the chronically tra

23 Indeed, during its early evolution, transfusion medicine focused almost exclusively on issue

24 AABB and the International Collaboration for Transfusion Medicine Guidelines (the use of leukoreducti

25 AABB and the International Collaboration for Transfusion Medicine Guidelines.

26 Transfusion medicine has become a broad, multidisciplina

27 Implementation of molecular testing for transfusion medicine has been a conservative process and

28 years, the translation of basic research in transfusion medicine has led to development of novel cel

29 Conclusions and Relevance: Research in RBC transfusion medicine has significantly advanced the scie

30 Advances in transfusion medicine have made blood supply safer than e

31 The role of transfusion medicine in sickle cell disease is also incr

32 offers an important view into the future of transfusion medicine in the operating room, as well as i

33 ions of healthcare information technology to transfusion medicine include creation of electronic repo

34 tforward but require staff with expertise in transfusion medicine, intensive teamwork, patient-specif

35 The evolution of transfusion medicine into a clinically oriented discipli

36 matologists, transplantation physicians, and transfusion medicine physicians, the data and opinions p

37 bacterial sepsis is a persistent problem in transfusion medicine, posing a greater threat than the c

38 group antigens and antibodies as applied to transfusion medicine practice.

39 is neither monitored nor managed by current transfusion medicine practice; however, the current data

40 tologist, neurologist, neuroradiologist, and transfusion medicine specialist); prompt neuro-imaging a

41 th challenging hemostatic complications, and transfusion medicine specialists should collaborate to d

42 shed in the College of American Pathologists Transfusion Medicine Survey Sets and in a national surve

43 The next series of advances in transfusion medicine will complement the current approac

44 tion of healthcare information technology to transfusion medicine will expand, as more institutions e

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。